![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
News
Agenus begins Phase 1/2 Clinical Trial of anti-PD-1 Â Antibody
Agenus Inc , an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced that the first patient has...
Press Releases
Aldeyra Therapeutics Confirms FDA Orphan Drug Designation for ADX-102 in Sjogren-Larsson
Aldeyra Therapeutics, Inc. , a clinical-stage biotech company devoted to treating diseases thought to be related to endogenous aldehydes. AÂ naturally occurring...
Press Releases
Oramed Granted European Patent For Combination Oral Insulin And Glp-1 Analog Capsule
Oramed Pharmaceuticals Inc (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that the European Patent Office has...
News
Medical fair thailand 2017 reflects the bullish growth of the Medical industry in the region
This year’s edition of MEDICAL FAIR THAILAND is set to be its biggest yet with more than 700 international exhibitors expected. 17 national and...
Press Releases
Food Processors Get a 360-Degree View of Line Performance with Mettler-Toledo’s ProdX 2.0
To supportglobal food manufacturers in meeting the documentation and active managerial control requirements of the Food Safety Modernisation Act (FSMA). When...
Drug Research
LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program
The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI) and SOTIO a.s. have signed a collaboration and license agreement providing SOTIO with...
News
Neurocrine Announces FDA Approval of INGREZZA TM Â CapsulesÂ
Neurocrine Biosciences, Inc. announced that the U.S. FDA has approved INGREZZATM (valbenazine) capsules for the treatment of adults with tardive dyskinesia (TD). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read